Hot Stocks
|
Greenlight Capital… Greenlight Capital disclosed in an SEC filing its holdings as of December 31, 2020. Greenlight Capital's new buys during the fourth quarter included Danimer Scientific (DNMR), FuboTV (FUBO), ADT Inc (ADT), Clover Health (CLOV), and EchoStar (SATS). The fund exited a number of positions during the quarter, including Intel (INTC), Ingredion (INGR), PVH Corp (PVH), Graham Holdings (GHC), and CryoLife (CRY). Greenlight increased its stake in Resideo (REZI), Teck Resources (TECK), CNX Resources (CNX), Dillards (DDS), and Atlas Air (AAWW), and reduced its stake in Jack in the Box (JACK), Intercept Pharma (ICPT), Chemours (CC), Crown Holdings (CCK), and NCR (NCR). ShowHide Related Items >><< - 02/16/21
- Teck Resources doubles water treatment capacity at Elkview operations
- 01/07/21
- Teck Resources, Ktunaxa Nation sign joint management agreement
- 11/27/20
- Teck Resources expands Copper and Health program to Chile
- 11/23/20
- Teck Resources increases steelmaking coal sales to China for Q4
- 01/15/21
- OneWeb receives additional funding from SoftBank, EchoStar
- 12/16/20
- EchoStar subsidiary Hughes awarded new $250M contract
- 12/09/20
- EchoStar subsidiary Hughes named as approved provider by GTA
- 12/04/20
- EchoStar Mobile partners with JT on hybrid network capability across Europe, UK
- 01/27/21
- Resideo launches process to refinance senior secured credit facilities
- 12/17/20
- Resideo names Travis Merrill Executive VP, Chief Strategy & Commercial Office
- 02/01/21
- PVH Corp. appoints Stefan Larsson as CEO
- 12/14/20
- Conagra Brands appoints Manny Chirico to board of directors
- 12/07/20
- PVH Corp. CEO sells 378.6K shares of common stock
- 11/23/20
- PVH Corp. appoints Best Buy's Chief Customer Officer Allison Peterson to board
- 02/09/21
- NCR incurred $202M of charges for excess inventory, software impairments
- 02/09/21
- NCR says Covid will negatively impact business into 2021
- 02/09/21
- Cardtronics to cease conducting quarterly earnings conference calls
- 02/08/21
- NCR Corp. announces the acquisition of solutions provider Terafina
- 01/28/21
- Jack in the Box names Ryan Ostrom as new CMO
- 12/17/20
- Jack in the Box names Timothy Mullany as new CFO
- 11/19/20
- Jack in the Box CEO says team working on new chicken program
- 11/18/20
- Jack in the Box jumps 4% to $90.20 after Q4 earnings beat
- 02/01/21
- Vuzix reports dividend settlement pact, sale of stake by Intel
- 01/28/21
- Intel CFO buys 9.1K shares of common stock
- 01/27/21
- Intel CEO buys 27.2K shares of common stock
- 01/21/21
- Intel announces 5% increase to quarterly cash dividend
- 02/12/21
- Ingredion, Group Arcor announce joint venture in Argentina, Chile, Uruguay
- 12/18/20
- Ingredion appoints Eric Seip as chief supply chain officer
- 11/16/20
- Einhorn's Greenlight buys Twitter, exits Whirlpool in Q3
- 11/01/20
- Ingredion to acquire 100% ownership in Verdient Foods
- 01/27/21
- Intercept believes RBC note on completion of safety review is incorrect
- 01/27/21
- Intercept says FDA website does not indicate safety review completed
- 01/11/21
- Intercept appoints Jared Freedberg as general counsel, secretary
- 12/10/20
- Intercept CEO Mark Pruzanski to step down, Jerry Durso to succeed
- $601.52 /
-14.18 (-2.30%) - 12/20/20
- Fly Intel: Top five weekend stock stories
- 11/10/20
- Graham Holdings to sell Megaphone to Spotify for $235M
- 09/10/20
- Graham Holdings to repurchase up to 500,000 class B shares
- 01/21/21
- Greenlight says FuboTV bear case misunderstands sports wagering opportunity
- 01/21/21
- Greenlight owns shares, warrants of FuboTV at average price of $5
- 01/21/21
- FuboTV rises 8.0%
- 01/29/21
- Danimer Scientific falls -12.2%
- 01/21/21
- Greenlight discloses new positions in Resideo and NCR, discusses FuboTV stake
- 01/21/21
- Danimer Scientific rises 10.2%
- 01/21/21
- Danimer Scientific rises 12.1%
- 01/27/21
- Dillard's trading resumes
- 01/27/21
- Dillard's trading halted, volatility trading pause
- 10/12/20
- Dillard's rises 32.0%
- 10/12/20
- Dillard's rises 24.0%
- 09/02/20
- CryoLife acquires Ascyrus Medical
- 02/09/21
- CNX Resources announces total proved reserves of 9.55 Tcfe, up 13%
- 10/22/20
- CNX Resources rises after Bloomberg reports on EQT takeover interest
- 10/22/20
- CNX Resources jumps 16% to $11.99 after Bloomberg report of EQT bid
- 02/05/21
- Palihapitiya calls Hindenburg's comments on Clover 'spurious'
- 02/05/21
- Clover Health receives letter from SEC on investigation after Hindenburg article
- 02/05/21
- Clover Health says short seller firm's 'rife' with 'sweeping inaccuracies'
- 02/04/21
- Clover Health now down 9% to $12.66 after Hindenburg Research report
- 02/09/21
- Crown Holdings CEO says '-positioned for an excellent 2021'
- 01/19/21
- Crown Holdings Brazilian unit to build sixth beverage can plant
- 10/19/20
- Crown Holdings up 5% to $86 after Q3 results, guidance top estimates
- 10/19/20
- Crown Holdings to initiate dividend 'of at least' 20c beginning Q1 2021
- 01/22/21
- DuPont, Corteva and Chemours resolve legal disputes from 2015 spin-off
- 12/14/20
- Energy Fuels enters three-year monazite supply agreement with Chemours
- 11/03/20
- Chemours says all sites remain operational
- 02/10/21
- Ackerman Security Systems joins ADT Authorized Dealer Program
- 01/08/21
- Bill Miller lists DXC, ADT, Desktop Metal and Vroom as stock picks
- 01/08/21
- ADT Inc. shares offer 'very low risk,' Bill Miller says
- 12/10/20
- ADT Inc. closes acquisition of CellBounce
- 01/12/21
- Atlas Air orders four Boeing 747-8 Freighters
- 11/15/20
- Fly Intel: Top five weekend stock stories
- 11/05/20
- Atlas Air, Titan Aviation Holdings announce financing facilities
- 02/09/21 Jefferies
- Danimer Scientific price target raised to $66 from $49 at Jefferies
- 01/06/21 Jefferies
- Danimer Scientific initiated with a Buy at Jefferies
- 02/01/21 Wedbush
- FuboTV price target raised to $50 from $40 at Wedbush
- 01/21/21 Barrington
- FuboTV initiated with an Outperform at Barrington
- 01/19/21 LightShed Partners
- FuboTV price target lowered to $6.50 from $8 at LightShed Partners
- 01/12/21 Roth Capital
- FuboTV 'adds another piece to gaming puzzle' with deal, says Roth Capital
- 01/29/21 Citi
- ADT Inc. downgraded to Neutral from Buy at Citi
- 01/29/21 Citi
- ADT Inc. downgraded to Neutral from Buy at Citi
- 01/15/21 Deutsche Bank
- ADT Inc. assumed with a Hold at Deutsche Bank
- 11/06/20 Roth Capital
- Alarm.com price target raised to $75 from $65 at Roth Capital
- 02/02/21
- Fly Intel: Top five analyst initiations
- 02/02/21 Citi
- Clover Health initiated with a Buy at Citi
- 02/01/21 JPMorgan
- Clover Health initiated with a Neutral at JPMorgan
- 01/25/21 Citi
- EchoStar price target lowered to $27 from $30 at Citi
- 04/14/20 Citi
- EchoStar price target lowered to $36 from $45 at Citi
- 02/12/21 Lynx
- Intel price target raised to $75 from $70 at Lynx
- 02/08/21 Loop Capital
- MaxLinear upgraded to Buy from Hold at Loop Capital
- 02/01/21
- Fly Intel: Top five analyst downgrades
- 02/01/21 Northland
- Intel downgraded to Underperform from Market Perform at Northland
- 08/05/20 Credit Suisse
- Ingredion price target raised to $90 from $77 at Credit Suisse
- 07/16/20 Berenberg
- Ingredion initiated with a Buy at Berenberg
- 06/25/20 Stephens
- Bunge named a Best Idea at Stephens
- 05/06/20 BMO Capital
- Ingredion price target lowered to $93 from $104 at BMO Capital
- 01/27/21 Citi
- PVH Corp. price target raised to $105 from $92 at Citi
- 01/21/21 Deutsche Bank
- PVH Corp. price target raised to $112 from $87 at Deutsche Bank
- 01/07/21 JPMorgan
- PVH Corp. price target raised to $101 from $88 at JPMorgan
- 12/30/20 Guggenheim
- PVH Corp. price target raised to $110 from $100 at Guggenheim
- $601.52 /
-14.18 (-2.30%) - 05/01/20 Lake Street
- CryoLife price target raised to $27 from $22 at Lake Street
- 04/03/20 Lake Street
- CryoLife price target lowered to $22 from $38 at Lake Street
- 04/02/20 Lake Street
- CryoLife should emerge stronger in coming years, says Lake Street
- 04/02/20 Needham
- CryoLife price target lowered to $29 from $38 at Needham
- 12/21/20 JPMorgan
- Resideo initiated with an Overweight at JPMorgan
- 12/14/20 Evercore ISI
- Resideo initiated with an Outperform at Evercore ISI
- 11/06/20 Roth Capital
- Resideo upgraded to Buy from Neutral at Roth Capital
- 08/12/20 Imperial Capital
- Resideo upgraded to Outperform from In-Line at Imperial Capital
- 02/10/21 JPMorgan
- Teck Resources initiated with an Overweight at JPMorgan
- 01/15/21 Raymond James
- Teck Resources price target raised to C$28 from C$23.50 at Raymond James
- 01/13/21 Deutsche Bank
- Teck Resources downgraded to Hold from Buy at Deutsche Bank
- 01/13/21 Deutsche Bank
- Teck Resources downgraded to Hold from Buy at Deutsche Bank
- 01/15/21 JPMorgan
- CNX Resources initiated with an Overweight at JPMorgan
- 12/15/20 BofA
- CNX Resources initiated with a Neutral at BofA
- 12/15/20 BofA
- CNX Resources initiated with a Neutral at BofA
- 10/30/20 MKM Partners
- CNX Resources upgraded to Buy from Neutral at MKM Partners
- 02/16/21 JPMorgan
- Dillard's price target raised to $49 from $42 at JPMorgan
- 01/21/21 Deutsche Bank
- Dillard's upgraded to Hold from Sell at Deutsche Bank
- 01/21/21 Deutsche Bank
- Dillard's upgraded to Hold from Sell at Deutsche Bank
- 01/04/21 JPMorgan
- Dillard's price target raised to $42 from $41 at JPMorgan
- 01/07/21 Wolfe Research
- Atlas Air downgraded to Peer Perform from Outperform at Wolfe Research
- 11/06/20 Susquehanna
- Atlas Air price target raised to $87 from $79 at Susquehanna
- 10/22/20
- Fly Intel: Top five analyst initiations
- 10/22/20 Loop Capital
- Atlas Air initiated with a Buy at Loop Capital
- 02/12/21 UBS
- Jack in the Box price target raised to $100 from $95 at UBS
- 02/08/21 Deutsche Bank
- Jack in the Box price target raised to $113 from $107 at Deutsche Bank
- 02/03/21 OTR Global
- Jack in the Box upgraded to Positive from Mixed at OTR Global
- 01/29/21 Cowen
- Cowen upgrade Jack in the Box on brand revitalization
- 01/27/21 SVB Leerink
- SVB Leerink disagrees with RBC on conclusion of Intercept FDA review
- 01/19/21 Wedbush
- Intercept price target lowered to $106 from $116 at Wedbush
- 01/15/21 BofA
- Intercept downgraded to Underperform from Neutral at BofA
- 01/15/21 BofA
- Intercept downgraded to Underperform from Neutral at BofA
- 02/16/21 BMO Capital
- Chemours price target raised to $38 from $33 at BMO Capital
- 01/08/21 RBC Capital
- Chemours upgraded to Outperform from Sector Perform at RBC Capital
- 12/04/20 Barclays
- Chemours downgraded to Equal Weight ahead of PFAS news flow at Barclays
- 12/04/20 Barclays
- Chemours downgraded to Equal Weight from Overweight at Barclays
- 02/11/21 Citi
- Crown Holdings price target raised to $125 from $117 at Citi
- 02/11/21 Barclays
- Crown Holdings price target raised to $122 from $103 at Barclays
- 01/26/21 BMO Capital
- Sonoco Products downgraded to Market Perform from Outperform at BMO Capital
- 01/20/21 Deutsche Bank
- Crown Holdings price target raised to $112 from $104 at Deutsche Bank
- 02/10/21 Oppenheimer
- NCR Corp. price target raised to $45 from $40 at Oppenheimer
- 01/27/21 Morgan Stanley
- NCR Corp. price target raised to $47 from $42 at Morgan Stanley
- 01/26/21 Oppenheimer
- NCR Corp. price target raised to $40 from $35 at Oppenheimer
- 01/26/21 Wells Fargo
- NCR Corp. price target raised to $50 from $45 at Wells Fargo
- 10/27/20
- Teck Resources reports Q3 adj. EPS C$0.24 vs. C$0.69 last year
- 11/05/20
- EchoStar reports Q3 EPS 26c, consensus (10c)
- 01/27/21
- Resideo sees Q4 revenue approximately $1.5B, consensus $1.39B
- 11/05/20
- Resideo sees Q4 revenue $1.36B-$1.41B, consensus $1.3B
- 11/05/20
- Resideo reports Q3 EPS 60c, consensus 5c
- 12/02/20
- PVH Corp. sees Q4 revenue down about 20% from last year
- 12/02/20
- PVH Corp. reports Q3 EPS $1.32, consensus 24c
- 12/02/20
- Notable companies reporting after market close
- 09/02/20
- PVH Corp. reports Q2 EPS 13c, consensus ($2.42)
- 02/09/21
- NCR Corp. reports Q4 EPS 59c, consensus 62c
- 10/27/20
- NCR Corp. reports Q3 EPS 54c, consensus 39c
- 11/18/20
- Jack in the Box not providing FY21 guidance
- 11/18/20
- Jack in the Box reports Q4 adjusted EPS $1.61, consensus $1.14
- 11/18/20
- Notable companies reporting after market close
- 01/21/21
- Intel sees Q1 EPS $1.10, consensus 93c
- 01/21/21
- Intel reports Q4 EPS $1.52, consensus $1.10
- 01/21/21
- Notable companies reporting after market close
- 01/13/21
- Intel sees Q4 revenue and EPS to exceed prior guidance
- 02/03/21
- Ingredion sees 2021 revenue "modestly up", consensus $6.42
- 02/03/21
- Ingredion reports Q4 adjusted EPS $1.75, consensus $1.46
- 11/01/20
- Ingredion reports Q3 adj. EPS $1.77, consensus $1.45
- 11/09/20
- Intercept narrows 2020 Ocaliva sales view $310-$320M from $300M-$320M
- 11/09/20
- Intercept reports Q3 EPS ($2.01), consensus ($1.93)
- 01/05/21
- FuboTV reports preliminary Q4 revenue $94M-$98M, consensus $87.36M
- 11/10/20
- FuboTV sees FY21 revenue $415M-$435M, up 70% from last year, consensus $413.5M
- 11/10/20
- FuboTV sees Q4 revenue $80M-$85M, consensus $77.22M.
- 11/10/20
- FuboTV reports Q3 EPS ($1.65), consensus (37c)
- 11/12/20
- Dillard's reports Q3 EPS $1.43c vs 22c last year
- 02/11/21
- CryoLife reports Q4 non-GAAP EPS 20c, consensus 3c
- 11/04/20
- CryoLife reports Q3 non-GAAP EPS 13c, consensus (4c)
- 01/28/21
- CNX Resources reports Q4 EPS 87c, consensus 15c
- 02/09/21
- Crown Holdings sees FY21 adjusted EPS $6.60-$6.80, consensus $6.38
- 02/09/21
- Crown Holdings sees Q1 adjusted EPS $1.35-$1.40, consensus $1.26
- 02/09/21
- Crown Holdings reports Q4 adjusted EPS $1.50, consensus $1.27
- 10/19/20
- Crown Holdings sees FY20 adjusted EPS $5.65-$5.70, consensus $5.18
- 02/11/21
- Chemours sees FY21 adjusted EPS $2.40-$3.12, consensus $2.60
- 02/11/21
- Chemours reports Q4 adjusted EPS 61c, consensus 41c
- 11/03/20
- Chemours reports Q3 adjusted EPS 47c, consensus 33c
- 11/03/20
- Notable companies reporting after market close
- 01/19/21
- ADT Inc. reaffirms 2020 revenue view $5.2B-$5.35B, consensus $5.28B
- 11/05/20
- ADT Inc. sees FY20 revenue $5.25B-$5.35B, consensus $5.23B
- 11/05/20
- ADT Inc. reports Q3 ex-items EPS (8c), consensus 15c
- 11/05/20
- Atlas Air sees Q4 revenue approx. $850M, consensus $838.7M
- 11/05/20
- Atlas Air sees FY20 revenue approx. $3.1B, consensus $3.07B
|